US FDA approves two gene therapies for sickle cell disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. VRTS
6. GOOGL
7. SPY
8. HPE
9. SNOW
10. USO

Go back to US FDA approves two gene therapies for sickle cell disease
BLUEBIRD BIO (NASDAQ: BLUE) Delayed: 4.97 --0 (-0%)
Previous Close $4.97    52 Week High $95.28 
Open $4.97    52 Week Low $35.37 
Day High $4.97    P/E N/A 
Day Low $4.97    EPS $-1.81 
Volume 148       

(NASDAQ: CRSP) Delayed: 56.92 +0.10 (0.18%)
Previous Close $56.82    52 Week High $18.88 
Open $57.13    52 Week Low $13.75 
Day High $58.96    P/E N/A 
Day Low $55.59    EPS $0.00 
Volume 911,073       

Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Delayed: 556.75 +9.10 (1.66%)
Previous Close $547.65    52 Week High $134.71 
Open $552.42    52 Week Low $73.31 
Day High $558.36    P/E N/A 
Day Low $549.07    EPS $-1.98 
Volume 1,734,660